Absci Corporation (ABSI) vs Taysha Gene Therapies, Inc. (TSHA)
- Absci Corporation ABSI 7.58 +1.34%
- Taysha Gene Therapies, Inc. TSHA 4.01 −1.23%
Absci Corporation and Taysha Gene Therapies, Inc. are both Biotechnology companies. Absci Corporation and Taysha Gene Therapies, Inc. are of similar size ($1.3B and $1.3B). Taysha Gene Therapies, Inc. grew revenue faster over the last twelve months: 19.0% against −47.2%. Taysha Gene Therapies, Inc. has the higher net margin (0.00% vs −8,451.3%) and the higher return on invested capital (0.00% vs −182.0%). Across the 16 metrics below, Taysha Gene Therapies, Inc. leads on 11 and Absci Corporation on 5.
Valuation
Profitability
| Metric | ABSI | TSHA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 70.18% |
| Operating margin | (8,812.31%) | 0.00% | 0.00% |
| Net margin | (8,451.31%) | 0.00% | 0.00% |
| Free cash flow margin | (7,550.91%) | 0.00% | 0.00% |
| Return on equity | (58.59%) | (54.18%) | (50.72%) |
| Return on assets | (51.87%) | (41.52%) | (45.56%) |
| Return on invested capital | (181.96%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack